HEMASTAT Trademark
Trademark Overview
On Thursday, June 6, 2024, a trademark application was filed for HEMASTAT with the United States Patent and Trademark Office. The USPTO has given the HEMASTAT trademark a serial number of 98587917. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Thursday, December 19, 2024. This trademark is owned by Zetagen Therapeutics, Inc.. The HEMASTAT trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:
Biological tissue grafts; absorbable powder particles for use as a surgical wound dressing; biomaterial surgical sealants; surgical implants comprising living tissues; Chemical preparations for medical purposes, namely, for improving blood coagulation and supporting natural blood cascade during surgical procedures and emergency treatments
Surgical implants comprising artificial material with a blood clotting coating; medical devices for administering absorbable powder particles for use as a surgical wound dressing and surgical implants comprising artificial material with a blood clotting coating
General Information
| Serial Number | 98587917 |
| Word Mark | HEMASTAT |
| Filing Date | Thursday, June 6, 2024 |
| Status | 641 - NON-FINAL ACTION - MAILED |
| Status Date | Thursday, December 19, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Biological tissue grafts; absorbable powder particles for use as a surgical wound dressing; biomaterial surgical sealants; surgical implants comprising living tissues; Chemical preparations for medical purposes, namely, for improving blood coagulation and supporting natural blood cascade during surgical procedures and emergency treatments |
| Pseudo Mark | HEMA STAT |
| Goods and Services | Surgical implants comprising artificial material with a blood clotting coating; medical devices for administering absorbable powder particles for use as a surgical wound dressing and surgical implants comprising artificial material with a blood clotting coating |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, June 6, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, June 6, 2024 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Zetagen Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Syracuse, NY 13210 |
Trademark Events
| Event Date | Event Description |
| Thursday, June 6, 2024 | NEW APPLICATION ENTERED |
| Wednesday, December 18, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, December 19, 2024 | ASSIGNED TO EXAMINER |
| Thursday, December 19, 2024 | NON-FINAL ACTION E-MAILED |
| Thursday, December 19, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, December 19, 2024 | NON-FINAL ACTION WRITTEN |
